Download as pdf or txt
Download as pdf or txt
You are on page 1of 1

NEWS, NEWS NEWS

NEWS 67 OCTOBER 2001

ASTHMA
The world’s largest asthma study seems to discount the notion that environmental aller-
gens could account for the huge variation in asthma rates across Europe, but does link
paracetamol use with increased susceptibility to asthma. The European community respi-
ratory health survey, a cross sectional study of atopy, asthma, and other chronic respira-
tory disorders, was carried out in 22 countries around the world (mostly in Europe) during
the early 1990s and involved around 140,000 participants. It found a fourfold difference in
the prevalence of nasal allergy between the most and least affected countries, a sixfold
difference in the prevalence of current asthma, and an eightfold difference in the preva-
lence of wheezing. Britain, Ireland, Australia, New Zealand and the United States had the
most asthma, while low rates were found in Iceland, Norway, Spain, Germany, Italy,
Algeria, India, and the former Warsaw Pact countries. A strong genetic association was
found in both asthma and atopy. Children whose mothers had asthma were at 3.2 times
more likely to develop the disease, 2.9 times if the father had asthma, and 7 times if both
parents had asthma. Having a large number of siblings seems to reduce the risk of asthma
and of allergy. House dust mites and cat allergens were the most frequent allergic causes
of airway constriction. However allergic sensitisation accounted for only 13% of the over-
all variation in bronchial responsiveness. With paracetamol use it was found that the
prevalence of wheezing in 13-14 year olds increased by 0.5% for every gram of drug taken
per person per year. It is not known whether this might be due to an actual effect of para-
cetamol, or an unexplained preventive effect of aspirin in countries where it is preferred to
paracetamol. (European Respiratory Journal (2001;18:598-611); BMJ 2001;323:592, 15/9/01).

You might also like